Christopher Cabell - Net Worth and Insider Trading
Christopher Cabell Net Worth
The estimated net worth of Christopher Cabell is at least $0 dollars as of 2024-11-29. Christopher Cabell is the EVP, Head of R&D, and CMO of Arena Pharmaceuticals Inc and owns about 0 shares of Arena Pharmaceuticals Inc (ARNA) stock worth over $0. Details can be seen in Christopher Cabell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Cabell has not made any transactions after 2020-07-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Cabell
Christopher Cabell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Cabell owns 3 companies in total, including Pulmatrix Inc (PULM) , Arena Pharmaceuticals Inc (ARNA) , and Zura Bio Ltd (ZURA) .
Click here to see the complete history of Christopher Cabell’s form 4 insider trades.
Insider Ownership Summary of Christopher Cabell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PULM | Pulmatrix Inc | 2020-06-23 | director |
| ARNA | Arena Pharmaceuticals Inc | 2020-07-15 | EVP & Head of R&D & and CMO |
| ZURA | Zura Bio Ltd | 2023-03-20 | EVP and CMO |
Christopher Cabell Latest Holdings Summary
Christopher Cabell currently owns a total of 1 stock. Christopher Cabell owns 0 shares of Arena Pharmaceuticals Inc (ARNA) as of July 15, 2020, with a value of $0.
Latest Holdings of Christopher Cabell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARNA | Arena Pharmaceuticals Inc | 2020-07-15 | 0 | 99.99 | 0 |
Holding Weightings of Christopher Cabell
Christopher Cabell Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Cabell has made a total of 1 transactions in Arena Pharmaceuticals Inc (ARNA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Arena Pharmaceuticals Inc is the sale of 13,000 shares on July 15, 2020, which brought Christopher Cabell around $884,000.
Insider Trading History of Christopher Cabell
- 1
Christopher Cabell Trading Performance
Christopher Cabell Ownership Network
Christopher Cabell Owned Company Details
What does Pulmatrix Inc do?
Who are the key executives at Pulmatrix Inc?
Christopher Cabell is the director of Pulmatrix Inc. Other key executives at Pulmatrix Inc include Interim CFO Peter Ludlum , Chief Medical Officer Margaret Wasilewski , and Vice President & Finance Michelle Siegert .
Pulmatrix Inc (PULM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Pulmatrix Inc (PULM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pulmatrix Inc (PULM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Pulmatrix Inc (PULM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pulmatrix Inc Insider Transactions
Christopher Cabell Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Cabell. You might contact Christopher Cabell via mailing address: C/o Arena Pharmaceuticals, Inc., 6154 Nancy Ridge Drive, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
